Dergiler / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 3

Dual effect of epigallocatechine gallate on the pathology of Alzheimer’s: Cholinesterases and amyloidogenesis

Sayfa
190–197
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our results indicated that epigallocatechin gallate may be accepted as a candidate molecule as the dual effective drugs for neurodegenerative diseases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: To evaluate the dual inhibitory effect of epigallocatechin gallate on Alzheimer’s pathogenesis.
📊
Temel Bulgular & Veri:Methods: Cholinesterase inhibition studies were performed by kinetic Ellman methods and also the inhibitory effect of molecule on amyloid fibrillation is determined by dye binding thioflavin T method.
💡
Sonuç & Katkı:Conclusion: Our results indicated that epigallocatechin gallate may be accepted as a candidate molecule as the dual effective drugs for neurodegenerative diseases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: To evaluate the dual inhibitory effect of epigallocatechin gallate on Alzheimer’s pathogenesis. Methods: Cholinesterase inhibition studies were performed by kinetic Ellman methods and also the inhibitory effect of molecule on amyloid fibrillation is determined by dye binding thioflavin T method. Results: Epigallocatechin gallate inhibited both types of cholinesterases and amyloid fibrillation. The inhibition of acetylcholinesterase indicated an uncompetitive inhibition whereas butyrylcholinesterase inhibition had an unique pattern. Compound inhibited butyrylcholinesterase with two types of inhibition in a dose related manner. Fibrillation destabilization is also observed by the compound. Conclusion: Our results indicated that epigallocatechin gallate may be accepted as a candidate molecule as the dual effective drugs for neurodegenerative diseases.

🔖

Bu Makaleye Atıf Yap

ÖZER, E. Ö. (2021). Dual effect of epigallocatechine gallate on the pathology of Alzheimer’s: Cholinesterases and amyloidogenesis. Experimental Biomedical Research, Cilt: 4 - Sayı: 3, 190–197. https://ajindex.com/articles/348214

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Ryan P, Hynes MJ. The kinetics and mechanisms of the complex formation and antioxidant behaviour of polyphenols EGCG and ECG with iron. J Inorganic Biochem.2007
  2. 101(4): 585-93. [2]Ren-You G, Hua-Bin L, Zhong-Quan Su, et al. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit. Rev. Food Sci Nutr. 2018
  3. 58(6): 924–41. [3]Kumarn VS, Arulmahti K, Srividhya R et al. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp Gerontol. 2007
  4. 43(3): 176-83. [4]Okello EJ, Mather J. Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer’s Disease. Nutrients. 2020
  5. 12(4): 1090-2013. [5]Uddin S, Kabir T, Niaz K, et al. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease. Molecules.2020
  6. 25(6): 1267-96. [6]Maltsev AV, Bystryak S, Galzitskaya OV. The role of -amyloid peptide in neurodegenerative diseases. Ageing Res Rev. 2011
  7. 10(4): 440–52. [7]Parihar, MS, Hemnani T. Alzheimer’s disease pathogenesis ve therapeutic interventions. J Clin Neurosci. 2004
  8. 11(5): 46–67. [8]Clippingdale AB, Wade JD, Colin W. The amyloid--peptide ve its role in Alzheimer disease. J Pept Sci. 2001
  9. 7(5): 227–49. [9]Selkoe DJ. Physiological production of the β-amyloid protein ve the mechanism of Alzheimer's disease. Trends Neurosci. 1999
  10. 16(10): 403–409. [10] Ferrari GV, Canales MA, Shin I, et al. A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry-US. 2001
  11. 40(45):10447-457. [11] Luo W, Li YP, He Y. Design, synthesis and evaluation of novel tacrinemultialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation. Bioorg Med Chem. 2001
  12. 19(2): 63–770. [12] Morgana C, Colombres M, Nunez MT, and Inestrosa NC. Structure and function of amyloid in Alzheimer’s disease. Prog Neurobiol. 2004
  13. 74(6): 323–49. [13] Yanbei T, Chuanhai W, Yunyao K, et al. Bioactivity-guided identification of flavonoids with cholinesterase and βamyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa. Bioorg Med Chem Lett. 2019
  14. 29(10): 1194-98. [14] Ellman, GL, Courtney KD, Veres VJr, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961
  15. Groenning M, Olsen L, Van-de-Weert M